Introduction of innovations on the market by EuroPharma Alliance sp. z o.o. (Q95032): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Created claim: summary (P836): The project consists of the creation of appropriate technical infrastructure, by creating an innovative line to fill the atomisers in the airless system, in order to implement the innovative products on the market and to bring the process into the process of bringing proceedings. The project will result in innovative solutions in the world. The project will have a positive impact on increasing the company’s employment (minimum 2 jobs in the fram...)
Property / summary
 
The project consists of the creation of appropriate technical infrastructure, by creating an innovative line to fill the atomisers in the airless system, in order to implement the innovative products on the market and to bring the process into the process of bringing proceedings. The project will result in innovative solutions in the world. The project will have a positive impact on increasing the company’s employment (minimum 2 jobs in the framework of the employment contract) on horizontal policies, introducing new solutions in the sphere of eco-innovation, on environmentally friendly solutions and increasing the revenues of the company. As a result of the project, the company will bring to the market a new type of product which it has not yet offered to expand with new market outlets and new customer positions. The project involves the acquisition of a production line that will serve to produce products currently not present in the industry. The total value of the project is 1230000. Eligible costs: PLN 1000000. The new technology will offer the Applicant a number of improvements and competitive advantages. Precise, repeatable doses of the food supplement will reduce the demand for consumption in order to propose more concentrated and accurate doses. The air-tightness of the packaging, the lack of air access even during the use of the product will prolong the durability of the product, allow consumers to reach the product repeatedly without any risk of oxidation, rancidity and other degradation resulting from the use of the product. The wide range of possibilities offered by the new line technology means that it will be able to execute the order to any group of clients of the firm, i.e.: marketing organisations marketing pharmaceutical products and food supplements composed of both national entities (Walmark, Polfarmex, Valentina, ICN Polfa Rzeszów) and abroad (90 % of the sales of the company are sales via foreign distributors under their own brands, for example: NattoPharma ASA). (English)
Property / summary: The project consists of the creation of appropriate technical infrastructure, by creating an innovative line to fill the atomisers in the airless system, in order to implement the innovative products on the market and to bring the process into the process of bringing proceedings. The project will result in innovative solutions in the world. The project will have a positive impact on increasing the company’s employment (minimum 2 jobs in the framework of the employment contract) on horizontal policies, introducing new solutions in the sphere of eco-innovation, on environmentally friendly solutions and increasing the revenues of the company. As a result of the project, the company will bring to the market a new type of product which it has not yet offered to expand with new market outlets and new customer positions. The project involves the acquisition of a production line that will serve to produce products currently not present in the industry. The total value of the project is 1230000. Eligible costs: PLN 1000000. The new technology will offer the Applicant a number of improvements and competitive advantages. Precise, repeatable doses of the food supplement will reduce the demand for consumption in order to propose more concentrated and accurate doses. The air-tightness of the packaging, the lack of air access even during the use of the product will prolong the durability of the product, allow consumers to reach the product repeatedly without any risk of oxidation, rancidity and other degradation resulting from the use of the product. The wide range of possibilities offered by the new line technology means that it will be able to execute the order to any group of clients of the firm, i.e.: marketing organisations marketing pharmaceutical products and food supplements composed of both national entities (Walmark, Polfarmex, Valentina, ICN Polfa Rzeszów) and abroad (90 % of the sales of the company are sales via foreign distributors under their own brands, for example: NattoPharma ASA). (English) / rank
 
Normal rank

Revision as of 07:04, 6 March 2020

Project in Poland financed by DG Regio
Language Label Description Also known as
English
Introduction of innovations on the market by EuroPharma Alliance sp. z o.o.
Project in Poland financed by DG Regio

    Statements

    0 references
    420,000.0 zloty
    0 references
    100,800.0 Euro
    13 January 2020
    0 references
    1,230,000.0 zloty
    0 references
    295,200.0 Euro
    13 January 2020
    0 references
    42.0 percent
    0 references
    1 January 2020
    0 references
    31 December 2020
    0 references
    EUROPHARMA ALLIANCE SP. Z O.O.
    0 references

    50°58'48.4"N, 17°2'27.2"E
    0 references
    Projekt polega na stworzeniu odpowiedniej infrastruktury technicznej, poprzez stworzenie innowacyjnej linii do napełniania atomizerów w systemie airless, w celu wdrożenia na rynek innowacyjnych produktów oraz wprowadzenia do cyklu produkcyjnego innowacji procesowej. Rezultatem projektu będą innowacyjne w skali świata rozwiązania. Projekt będzie miał pozytywny wpływ na zwiększenie zatrudnienia w firmie (minimum 2 nowe miejsce pracy w ramach umowy o pracę) na polityki horyzontalne, wprowadzenie nowych rozwiązań w sferze ekoinnowacji, na rozwiązania pro-środowiskowe oraz zwiększenie przychodów w firmie. W wyniku realizacji projektu, firma wdroży do na rynek nowy typ produktu, którego do tej pory nie oferowała, dzięki czemu rozszerzy działalność o nowe rynki zbytu oraz pozyska nowych klientów. Projekt zakłada nabycie linii produkcyjnej, która będzie służyła do wytwarzania produktów obecnie nie występujących w branży. Całkowita wartość projektu to 1230000. Koszty kwalifikowane: 1000000 zł. Nowa technologia zaoferuje Wnioskodawcy szereg ulepszeń i przewag konkurencyjnych. Precyzyjne, powtarzalne dozowanie suplementu diety zmniejszy zapotrzebowanie na jego konsumpcję pozwoli zaproponować bardziej skoncentrowane i dokładne dawki. Szczelność opakowania, brak dostępu powietrza nawet podczas użytkowania produktu wydłuży termin trwałości produktu, pozwoli konsumentom sięgać do niego wielokrotnie bez ryzyka utlenienia, jełczenia lub innego pogorszenia jakości wynikającego z używania produktu. Szeroki wachlarz możliwości, który daje wykorzystanie technologii nowej linii powoduje, że będzie mogła on realizować zlecenie u każdej grupy klientów firmy tj.: organizacji marketingowych komercjalizujących produkty farmaceutyczne i suplementy diety, w skład których wchodzą zarówno podmioty krajowe (Walmark , Polfarmex , Valentis, ICN Polfa Rzeszów), a także zagraniczne (90% sprzedaży firmy to sprzedaż poprzez zagranicznych dystrybutorów pod ich markami np. NattoPharma ASA). (Polish)
    0 references
    The project consists of the creation of appropriate technical infrastructure, by creating an innovative line to fill the atomisers in the airless system, in order to implement the innovative products on the market and to bring the process into the process of bringing proceedings. The project will result in innovative solutions in the world. The project will have a positive impact on increasing the company’s employment (minimum 2 jobs in the framework of the employment contract) on horizontal policies, introducing new solutions in the sphere of eco-innovation, on environmentally friendly solutions and increasing the revenues of the company. As a result of the project, the company will bring to the market a new type of product which it has not yet offered to expand with new market outlets and new customer positions. The project involves the acquisition of a production line that will serve to produce products currently not present in the industry. The total value of the project is 1230000. Eligible costs: PLN 1000000. The new technology will offer the Applicant a number of improvements and competitive advantages. Precise, repeatable doses of the food supplement will reduce the demand for consumption in order to propose more concentrated and accurate doses. The air-tightness of the packaging, the lack of air access even during the use of the product will prolong the durability of the product, allow consumers to reach the product repeatedly without any risk of oxidation, rancidity and other degradation resulting from the use of the product. The wide range of possibilities offered by the new line technology means that it will be able to execute the order to any group of clients of the firm, i.e.: marketing organisations marketing pharmaceutical products and food supplements composed of both national entities (Walmark, Polfarmex, Valentina, ICN Polfa Rzeszów) and abroad (90 % of the sales of the company are sales via foreign distributors under their own brands, for example: NattoPharma ASA). (English)
    0 references

    Identifiers

    RPDS.01.05.01-02-0171/18
    0 references